Defensins and cathelicidins as natural peptide antibiotics;Defensyny i katelicydyny jako naturalne antybiotyki peptydowe

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 694-707

  Witkowska, Danuta ^a   Bartys̈, Arkadiusz ^a   Gamian, Andrzej ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Antimicrobial peptides; Cathelicidins; Cationic peptides; Chemotaxis; Defensins; Innate immunity; Leukocytes; Natural antibiotics; and defensins

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; DEFENSIN;

ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; CATHELICIDINS; DEFENSINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS;

EID: 63149151694     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (111)

1. Aarbiou J., Ertmann M., van Wetering S., van Noort P., Rook D., Rabe K.F., Litvinov S.V., van Krieken J.H., de Boer W.I., Hiemstra P.S.: Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J. Leuc. Biol., 2002; 72: 167-174
2. Aarbiou J., Verhoosel R.M., van Wetering S., de Boer W.I., van Krieken J.H., Litvinov S.V., Rabe K.F., Hiemstra P.S.: Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am. J. Resp. Cell Mol. Biol., 2004; 30: 193-201
3. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H.: The human antimicrobial and chemotactic peptides LL-37 and a-defensins are expressed by specific lymphocyte and monocyte populations. Blood, 2000; 96: 3086-3093
4. Agerberth B., Grunewald J., Castanos-Velez E., Olsson B., Jornvall H., Wigzell H., Eklund A., Gudmundsson G.H.: Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med., 1999; 160: 283-290
5. Andra J., Gutsmann T., Garidel P., Brandenburg K.: Mechanisms of endotoxin neutralization by synthetic cationic compounds. J. Endotoxin. Res., 2006; 12: 261-277
6. Bals R.: Epithelial antimicrobial peptides in host defense against infection. Respir. Res., 2001; 1: 141
7. Bals R., Hiemstra P.S.: Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J., 2004; 23: 327-333
8. Bauer F., Schweimer K., Kluver E., Conejo-Garcia J.R., Forssmann W.G., Rosch P., Adermann K., Sticht H.: Structure determination of human and murine β-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci., 2001; 10: 2470-2479
9. Bevins C.L.: The Paneth cell and innate immune response. Curr. Opin. Gastroenterol., 2004; 20: 572-580
10. Bevins C.L., Martin-Porter E., Ganz T.: Defensins and innate host defence of the gastrointestinal tract. Gut, 1999; 45: 911-915
11. Biragyn A.: Defensins-non-antibiotic use for vaccine development. Curr. Protein Pept. Sci., 2005; 6: 53-60
12. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., Kwak L.W.: Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science, 2002; 298: 1025-1029
13. Boman H.G.: Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med., 2003; 254: 197-215
14. Borregaard N., Elsbach P., Ganz T., Garred P., Svejgaard A.: Innate immunity: from plants to humans. Immunol. Today, 2000; 21: 68-70
15. Borregaard N., Lollike K., Kjelsden L., Sengelov H., Bastholm L., Nielsen M.H., Bainton D.F.: Human neutrophil granules and secretory vesicles. Eur. J. Haematol., 1993; 51: 187-198
16. Bowdish D.M., Davidson D.J., Hancock R.E.: A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci., 2005; 6: 35-51
17. Broekaert W.F., Terras F.R., Cammue B.P., Osborn R.W.: Plant defensins: novel antimicrobial peptides as components of the host defense system. Plant Physiol., 1995; 108: 1353-1358
18. Brogden K.A.: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol., 2005; 3: 238-250
19. Bulet P., Stocklin R., Menin L.: Anti-microbial peptides: from intervertebres to vertebras. Immunol. Rev., 2004; 198: 169-184
20. Campopiano D.J., Clarke D.J., Polfer N.C., Barran P.E., Langley R.J., Govan J.R., Maxwell A., Dorin J.R.: Structure activity relationships in defensin dimers. A novel link between β-defensin tertiary structure and antimicrobial activity. J. Biol. Chem., 2004; 279: 48671-48679
21. Chen X., Howe J., Andra J., Rossle M., Richter W., da Silva A.P., Krensky A.M., Clayberger C., Brandenburg K.: Biophysical analysis of interaction of granulysin-derived peptides with enterobacterial endotoxins. Biochim. Biophys. Acta, 2007; 1768: 2421-2431
22. Chong K.T., Xiang L., Wang X., Jun E.L., Xi L., Schweinfurth J.M.: High level expression of epithelial β-defensins (hBD-1, 2, and 3) in papillomavirus induced lesions. Vir. J., 2006; 3: 75
23. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., Hokfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., Brauner A.: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med., 2006; 12: 636-641
24. Claeys S., de Belder T., Holtappels G., Gevaert P., Verhasselt B., van Cauwenberge P., Bachert C.: Human β-defensins and toll-like receptors in the upper airway. Allergy, 2003; 58: 748-753
25. ClinicalTrials.gov-A service of the U.S. NIH. http://clinicaltrials.gov (15-10.2008)
26. Cudic M., Otvos L.Jr.: Intracellular targets of antibacterial peptides. Curr. Drug Targets, 2002; 3: 101-106
27. Cunliffe R.N.: a-defensins in the gastrointestinal tract. Mol. Immunol., 2003; 40: 463-467
28. Cunliffe R.N., Rose F.R., Keyte J., Abberley L., Chan W.C., Mahida Y.R.: Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and methaplastic Paneth cells in colon in inflammatory bowel disease. Gut, 2001; 48: 176-185
29. Dale B.A. Krisanaprakornkit S.: Defensins antimicrobial peptides in the oral cavity. J. Oral Pathol. Med., 2001; 30: 321-327
30. De Smet K., Contreras R.: Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett., 2005; 18: 1337-1347
31. Diamond G., Zasloff M., Eck H., Brasseur M., Maloy W.L., Bevins C.L.: Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: Peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. USA, 1991; 88: 3952-3956
32. Durr M., Peschel A.: Chemokines meet defensins: The merging concept of chemoattractants and antimicrobial peptides in host defense. Infect. Immun., 2002; 70: 6515-6517
33. Ericksen B., Wu Z., Lu W., Lehrer R.I.: Antibacterial activity and specificity of the six human a-defensins. Antimicrob. Agents Chemother., 2005; 49: 269-275
34. Fedtke I. Gotz F. Peschel A.: Bacterial evasion of innate host defenses-The Staphylococcus aureus lesson. Int. J. Med. Microbiol., 2004; 294: 189-194
35. Fukuoka S., Howe J., Andra J., Gutsmann T., Rossle M., Brandenburg K.: Physico-chemical and biophysical study of the interaction of hexaand heptaacyl lipid A from Erwinia carotovora with magainin 2-derived antimicrobial peptides. Biochim. Biophys. Acta, 2008; 1778: 2051-2057
36. Gallo R.I., Nizet V.: Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr. Allergy Asthma Rep., 2003; 3, 402-409
37. Ganz T.: Immunology. Versatile defensins. Science, 2002; 298: 977-979
38. Ganz T.: Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol., 2003; 3: 710-720
39. Ganz T.: Microbiology: Gut defence. Nature, 2003; 422: 478-479
40. Ganz T.: Antimicrobial polypeptides. J. Leukoc. Biol., 2004; 75: 34-38
41. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., Lehrer R.I.: Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest., 1985; 76: 1427-1435
42. Gidalevitz D., Ishitsuka Y., Muresan A.S., Konovalov O., Waring A.J., Lehrer R.I., Lee K.Y.: Interaction of antimicrobial peptide protegrin with biomembranes. Proc. Natl. Acad. Sci. USA, 2003; 100: 6302-6307
43. Groisman E.A., Parra-Lopez C., Salcedo M., Lipps C.J., Heffron F.: Resistance to host peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. USA, 1992; 89: 11939-11943
44. Hancock R.E., Rozek A.: Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett., 2002; 206: 143-149
45. Hattenbach L.O., Gumbel H., Kippenberger S.: Identification of betadefensins in human conjuctiva. Antimicrob. Agents Chemother., 1998; 42: 3332
46. Hiemstra P.S.: Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem. Soc. Trans., 2006; 34: 276-278
47. Hirsch J.G.: Phagocytin: A bactericidal substance from polymorphonuclear leukocytes. J. Exp. Med., 1956; 103: 589-611
48. Hirsch J.G., Cohn Z.A.: Degranulation of polymorphonuclear leukocytes following phagocytosis of microorganisms. J. Exp. Med., 1960; 112: 1005-1014
49. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A.: Phylogenetic perspectives in innate immunity. Science, 1999; 284: 1313-1318
50. Hubert P., Herman L., Maillard C., Caberg J.H., Nikkels A., Pierad G., Foidart J.M., Noel A., Boniver J., Delvenne P.: Defensins induce recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. The FASEB J., 2007; 21: 2765-2775
51. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G.: Downregulation of bactericidal peptides in enteric infection: A novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med., 2001; 7: 180-195
52. Jin T., Bokarewa M., Foster T., Mitchell J., Higgins J., Tarkowski A.: Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol., 2004; 172: 1169-1176
53. Kim C., Gajendran N., Mittrucker H.W., Weiwad M., Song Y.H., Hurwitz R., Wilmanns M., Fischer G., Kaufmann S.H.: Human adefensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. USA, 2005; 102: 4830-4835
54. Lehmann J., Retz M., Harder J., Krams M., Kellner U., Hartmann J., Hohgräve K., Raffenberg U., Gerber M., Loch T., Weichert-Jacobsen K., Stöckle M.: Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect. Dis., 2002; 2: 20
55. Lehrer R.I.: Primate defensins. Nat. Rev. Microbiol., 2004; 2: 727-738
56. Lehrer R.I., Ganz T.: Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol., 1999; 11: 23-27
57. Lehrer R.I., Ganz T.: Cathelicidins: A family of endogenous antimicrobial peptides. Curr. Opin. Hematol., 2002; 9: 18-22
58. Lehrer R.I., Ganz T.: Defensins of vertebrate animals. Curr. Opin. Immunol., 2002; 14: 96-102
59. Lehrer R.I., Lichtenstein A.K., Ganz T.: Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol., 1993; 11: 105-128
60. Liu A.Y., Destoumieux D., Wong A.V., Park C.H., Valore E.V., Liu L., Ganz T.: Human β-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Invest. Dermatol., 2002; 118: 275-281
61. Mallow E.B., Harris A., Salzman N., Russell J.P., DeBerardinis R.J., Ruchelli E., Bevins C.L.: Human enteric defensins. Gene structure and development expression. J. Biol. Chem., 1996; 271: 4038-4045
62. Marchini G., Lindow S., Brismar H., Stabi B., Berggren V., Ulfgren A.K., Lonne-Rahm S., Agerberth B., Gudmundsson G.H.: The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br. J. Dermatol., 2002; 147: 1127-1134
63. Markeeva N., Lysovskiy I., Zhuravel E., Soldatkina M., Lyzogubov V., Usenko V., Potapov V., Pogrebnoy P.: Involvement of human betadefensin-2 in proliferation of transformed cells of human cervix. Exp. Oncol., 2005; 27: 308-313
64. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., Heumann D.: Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-A by blocking the binding of LPS to CD14+ cells. J. Immunol., 2001; 167: 3329-3338
65. Nam M.J., Kee M.K., Kuick R., Hanash S.M.: Identification of defensin a-6 as a potential biomarker colon adenocarcinoma. J. Biol. Chem., 2005; 280: 8260-8265
66. NiedYwiedzka-Rystwej P., Deptua W.: Defensyny-wany wrodzony element ukadu odpornociowego u ssaków. Post. Hig. Med. Dow., 2008; 62: 524-529
67. Nizet V., Gallo R.L.: Cathelicidins and innate defense against invasive bacterial infection. Scand. J. Infect. Dis., 2003; 35: 670-676
68. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., Gallo R.L.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature, 2001; 414: 454-457
69. Ohara T., Morishita T., Suzuki H., Masaoka T., Nagata H., Hibi T.: Pathophysiological role of human β-defensin 2 in gastric mucosa. Intern. J. Mol. Med., 2004; 14: 1023-1027
70. O'Neil D.A., Cole S.P., Martin-Porter E., Housley M.P., Liu L., Ganz T., Kagnoff M.F.: Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect. Immun., 2000; 68: 5413-5415
71. Oppenheim J.J., Biragyn A., Kwak L.W., Yang D.: Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis., 2003; 62: ii17-ii21
72. Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., Shai Y.: Structure and organization of the human antibacterial peptide LL-37 in phospholipids membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J., 1999; 341: 501-513
73. Ouellette A.J.: Defensin-mediated innate immunity in the small intestine. Best Pract. Res. Clin. Gastroenterol., 2004; 18: 405-419
74. Ouellette A.J., Hsieh M.M., Nosek M.T., Cano-Gauci D.F., Huttner K.M., Buick R.N., Selsted M.E.: Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptidin isoforms. Infect. Immun., 1994; 62: 5040-5047
75. Ouellette A.J., Selsted M.E.: Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J., 1996; 10: 1280-1289
76. Pacova H., Kucera T., Astl J., Martinek J.: Detection of beta-defensins and NOS in healthy and pathological nasal mucosa. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub., 2004; 148: 239-240
77. Papagianni M.: Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol. Adv., 2003; 21: 465-499
78. Patrzykat A., Douglas S.E.: Antimicrobial peptides: cooperative approaches to protection. Protein Pept. Lett., 2005; 12: 19-25
79. Perron G.G., Zasloff M., Bell G.: Experimental evolution of resistance to an antimicrobial peptide. Proc. R. Sci., 2006; 273: 251-256
80. Peschel A., Collins L.V.: Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 2001; 22: 1651-1659
81. Philippott M.P.: Defensins and acne. Mol. Immunol., 2003; 40: 457-462
82. Raj P.A., Antonyraj K.J., Karunakaran T.: Large-scale synthesis and functional elements for antimicrobial activity of defensins. Biochem. J., 2000; 347: 633-641
83. Raqib R., Sarker P., Bergman P., Ara G., Lindh M., Sack D.A., Nasirul Islam K.M., Gudmundsson G.H., Andersson J., Agerberth B.: Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl. Acad. Sci. USA, 2006; 103: 9178-9183
84. Rosenberger C.M., Gallo R., Finlay B.B.: Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA, 2004; 101: 2422-2427
85. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., Bevins C.L.: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature, 2003; 422: 522-526
86. Schmidtchen A., Frick I.M., Andersson E., Tapper H., Björck L.: Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol., 2002; 46: 157-168
87. Selsted M.E., Harwig S.S., Ganz T., Schilling J.W., Lehrer R.I.: Primary structures of three neutrophil defensins. J. Clin. Invest., 1985; 76: 1436-1439
88. Serensen O.E.: The human cathelicidin hCAP-18. Dan. Med. Bull., 2005; 52: 1-10
89. Shafer W.M., Qu X., Waring A.J., Lehrer R.I.: Modulation of Neisseria gonorrhoeae susceptiobility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA, 1998; 95: 1829-1833
90. Skarnes R.C., Watson D.W.: Characterization of leukin: an antibacterial factor from leucocytes active against Gram-positive patogens. J. Exp. Med., 1956; 104: 829-845
91. Starner T.D., Agerberth B., Gudmundsson G.H., McCray P.B.Jr: Expression and activity of β-defensins and LL-37 in the developing human lung. J. Immunol., 2005; 174: 1608-1615
92. Szyk A., Wu Z., Tucker K., Yang D. Lu W., Lubkowski J.: Crystal structure of human a-defensin HNP4, HD5, and HD6. Protein Sci., 2006; 15: 2749-2760
93. Tang Y.Q., Yeaman M.R., Selsted M.E.: Antimicrobial peptides from human platelets. Infect. Immun., 2002; 70: 6524-6533
94. Tang Y.Q., Yuan J., Osapay G., Osapay K., Tran D., Miller C.J., Ouelette A.J., Selsted M.E.: A cyclic antimicrobial peptide produced in primate leucocytes by the ligation of two truncated a-defensins. Science 1999; 286: 498-502
95. Tomasinsig L., Zanetti M.: The cathelicidins-structure, function and evolution. Curr. Protein Pept. Sci., 2005; 6: 23-34
96. Uzzell T., Stolzenberg E.D., Shinnar A.E., Zasloff M.: Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides, 2003; 24: 1655-1667
97. van Wetering S., Sterk P.J., Rabe K.F., Hiemstra P.S.: Defensins: key players or bystander in infection, injury, and repair in the lung. J. Allergy Clin. Immunol., 1999; 104: 1131-1138
98. Wang W., Owen S.M., Rudolph D.L., Cole A.M., Hong T., Waring A.J., Lal R.B., Lehrer R.I.: Activity of a-and q-defensins against primary isolates of HIV-1. J. Immunol., 2004; 173: 515-520
99. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima H., Fellermann K., Ganz T., Stange E.F., Bevins C.L.: Reduced Paneth cell a-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA, 2005; 102: 18129-18134
100. Wehkamp J., Schmid M., Fellermann K., Stange E.F.: Defensins deficiency, intestinal microbes, and clinical phenotypes of Crohn's disease. J. Leukoc. Biol., 2005; 77: 460-465
101. Wiechua B, Tustanowski J.P., Martirosian G.: Peptydy antydrobnoustrojowe. Wiad. Lek., 2006; 59: 542-547
102. Wilson C.L., Ouellette A.J., Satchell D.P., Ayabe T., Lopez-Boado Y.S., Stratman J.L., Hultgren S.J., Matrisian L.M., Parks W.C.: Regulation of intestinal a-defensin activation by metalloproteinase matrilysin in innate host defense. Science, 1999; 286: 113-117
103. Yang D., Biragyn A., Hoover D.M., Lubkowski J., Oppenheim J.J.: Multiple roles of antimicrobial defensins, cathelicidins and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol., 2004; 22: 181-215
104. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J.: Mammalian defensins in immunity: more than just microbicidal. Trends Immunol., 2002; 23: 291-296
105. Yang D., Chertov O., Oppenheim J.J.: Participation of mammalian defensins and cathelicidins in antimicrobial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol., 2001; 69: 691-697
106. Yasin B., Wang W., Pang M., Cheshenko N., Hong T., Waring A.J., Herold B.C., Wagar E.A., Lehrer R.I.: q defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J. Virol., 2004; 78: 5147-5156
107. Zanetti M.: The role cathelicidins in innate host defenses of mammals. Curr. Issues Mol. Biol., 2005; 7: 179-196
108. Zanetti M., Gennaro R., Romeo D.: Cathelicidins: A novel protein family with common proregion and variable C-terminal antimicrobial domain. FEBS Lett., 1995; 374: 1-5
109. Zasloff M.: Reconstructing one of nature's designs. Trends Pharmacol. Sci., 2000; 7: 236-238
110. Zasloff M.: Antimicrobial peptides of multicellular organisms. Nature, 2002; 415: 389-395
111. Zasloff M.: Inducing endogenous antimicrobial peptides to battle infections. Proc. Natl. Acad. Sci. USA, 2006; 103: 8913-8914